Type 1 Diabetes 2017

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

By

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

By

Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

By

Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

By

With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.

Insulin Pump Associated With Fewer Complications Than Injections in Children, Adolescents

Insulin Pump Associated With Fewer Complications Than Injections in Children, Adolescents

By

Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

By

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

By

Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

By

Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.

CVD Risk Management in Type 1 Diabetes Improved With Metformin

CVD Risk Management in Type 1 Diabetes Improved With Metformin

By

Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.

Fast-Acting Insulin Aspart for Glycemic Control in Type 1 Diabetes

Fast-Acting Insulin Aspart for Glycemic Control in Type 1 Diabetes

By

Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.

Case Study: Diabetic Ketoacidosis Concerns in Type 1 Diabetes

Case Study: Diabetic Ketoacidosis Concerns in Type 1 Diabetes

By

After 3 days without taking insulin, a patient presents to the emergency room with hyperglycemia and concerns of diabetic ketoacidosis.

Diabetic Retinopathy Screening Should Be Individualized Based on Eye Health, Glycated Hemoglobin

Diabetic Retinopathy Screening Should Be Individualized Based on Eye Health, Glycated Hemoglobin

By

There is a 5% probability of progression from state 1 to state 5 between retinal screenings.

No Long Term Benefit to Adjuvant Metformin in Type 1 Diabetes

No Long Term Benefit to Adjuvant Metformin in Type 1 Diabetes

By

Adjuvant metformin produced a small but nonsignificant decrease in body mass index and insulin dose, but by year 10, no beneficial effects were evident.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

By

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Nutrition and Insulin Management Guidelines for Exercise in Type 1 Diabetes

Nutrition and Insulin Management Guidelines for Exercise in Type 1 Diabetes

By

Exercise management for patients with type 1 diabetes should be individualized, depending on insulin concentrations and exercise type/intensity.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

By

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

Islet Autoimmunity Risk Not Affected by Infant Formula Type

Islet Autoimmunity Risk Not Affected by Infant Formula Type

By

The use of hydrolyzed vs nonhydrolyzed cow's milk-based infant formula does not appear to reduce risk for islet autoimmunity.

Type 1 Diabetes Associated With Gut Inflammation

Type 1 Diabetes Associated With Gut Inflammation

By

People with type 1 diabetes have specific changes in gut bacteria and inflammation of the digestive tract compared with people without the disease.

Type 1 Diabetes Associated With Enterovirus in Children

Type 1 Diabetes Associated With Enterovirus in Children

By

A recent study confirms that frequent enterovirus infection may contribute to the development of type 1 diabetes in children.

Sign Up for Free e-Newsletters

CME Focus